Return to homepagePandemic Pact

Task V05: Development of Assays and Reagents for Coronavirus Vaccines

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201800013I-P00008-759302000002-2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2023

  • Known Financial Commitments (USD)

    $903,613

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    THOMAS RUDGE

  • Research Location

    United States of America

  • Lead Research Institution

    BATTELLE CENTERS/PUB HLTH RES & EVALUATN

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. These services will facilitate the development and introduction of new vaccine candidates and biologics (regulated by CBER) against potential agents of bioterrorism and emerging and re-emerging infectious diseases.